Picture of Codexis logo

CDXS — Codexis News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Codexis Inc reports results for the quarter ended in September - Earnings Summary

* Codexis Inc  CDXS.OQ  reported a quarterly adjusted loss
of 50
cents​​ per share for the quarter ended in September, lower than
the same quarter last year, when the company reported EPS of -15
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 32 cents per share. Wall Street expected
results to range from -37 cents to -27 cents per share.
    * Revenue fell 73.1% to $9.28 million from a year ago;
analysts
expected $10.03 million. 
    * Codexis Inc's reported EPS for the quarter was a loss
of 50
cents​.
    * The company reported a quarterly loss of $34.91 million.
    * Codexis Inc shares had fallen by 12.2% this quarter and
lost 64.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Codexis Inc is
$6.00 
This summary was machine generated from LSEG data November 2 at
09:54 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.32          -0.50          Missed
 Jun. 30 2023      -0.21          -0.17          Beat
 Mar. 31 2023      -0.31          -0.34          Missed
 Dec. 31 2022      -0.23          -0.14          Beat

Recent news on Codexis

See all news